How to eliminate MYCN-positive hepatic cancer stem cells to prevent the recurrence?

Proceedings of the National Academy of Sciences of the United States of America

Volumn 115, Issue 28, 2018, Pages E6388-E6389

  Yoshida, Go J ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

N MYC PROTO ONCOGENE PROTEIN; MYCN PROTEIN, HUMAN;

CANCER PREVENTION; CANCER RECURRENCE; CANCER STEM CELL; GENE AMPLIFICATION; HUMAN; LETTER; LIVER CELL CARCINOMA; ONCOGENE C MYB; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; NEUROBLASTOMA; TUMOR CELL LINE; TUMOR RECURRENCE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; N-MYC PROTO-ONCOGENE PROTEIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; NEUROBLASTOMA;

EID: 85049652092     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1808092115     Document Type: Letter

References (10)

1. Qin X-Y, et al. (2018) Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci USA 115:4969–4974.
2. Nio K, Yamashita T, Kaneko S (2017) The evolving concept of liver cancer stem cells. Mol Cancer 16:4.
3. Beltran H (2014) The N-myc oncogene: Maximizing its targets, regulation, and therapeutic potential. Mol Cancer Res 12:815–822.
4. Kramps C, Strieder V, Sapetschnig A, Suske G, Lutz W (2004) E2F and Sp1/Sp3 synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J Biol Chem 279:5110–5117.
5. Suenaga Y, et al. (2014) NCYM, a cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3β resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet 10:e1003996.
6. Rosen JM, Jordan CT (2009) The increasing complexity of the cancer stem cell paradigm. Science 324:1670–1673.
7. Redfern CP, Lovat PE, Malcolm AJ, Pearson AD (1995) Gene expression and neuroblastoma cell differentiation in response to retinoic acid: Differential effects of 9-cis and all-trans retinoic acid. Eur J Cancer 31A:486–494.
8. Wang ZY, Chen Z (2008) Acute promyelocytic leukemia: From highly fatal to highly curable. Blood 111:2505–2515.
9. Lee GY, Chun YS, Shin HW, Park JW (2016) Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia. Oncotarget 7:57442–57451.
10. Ren P, et al. (2015) ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation. J Pathol 235:90–100.